FOYA Program

Information about the Facility of the Year Awards program

Off
A member of the Roche group since 2009, Genentech discovers, develops, manufactures, and commercializes medicines for people with serious or life-threatening diseases. Their approach to the facility, flexibility of the...
News & Press Releases
08 September 2023
Explore how Genentech’s state-of-the-art Clinical Supply Center (CSC), awarded the ISPE Facility of the Year Awards (FOYA) in the Pharma 4.0TM category, embodies the Pharma 4.0 mindset through digital and automated technology integration. Operating...
News & Press Releases
08 September 2023
In an exclusive interview, Geoffrey Pot, the General Manager of Operations at Takeda's Lessines site, unveils Takeda's eco-friendly manufacturing approach. Recognized with the prestigious 2023 ISPE Facility of the Year Awards (FOYA) in the category...
Off
Chugai Pharmaceutical Building 48, known as FJ2, is an API facility for the manufacture of small and mid-size molecule drugs to be used for clinical development purposes. Located in the heart of Japan at a key...
Off
WuXi Biologics in Dundalk, Ireland, is contract research development and manufacturing (CRDMO) facility using hybrid, single-use, scale-out production technology for multiproduct mAb and recombinant protein drug...
Off
The SERUM’s NISHWAS project is recognized with the FOYA 2023 in the category “Supply Chain”, as it exemplifies how to deliver in a record time a large pharmaceutical manufacturing capability and capacity in condition of...
News & Press Releases
11 May 2023
ISPE announced the 2023 Facility of the Year Award Winners at the 2023 ISPE Europe Annual Conference in Amsterdam, The Netherlands. The award-winning projects selected by the FOYA program set the standard for pharmaceutical facilities of the future...
News & Press Releases
06 March 2023
For the first time in the history of the ISPE Facility of the Year Awards (FOYA) program , ISPE today announced the 2023 Facility of the Year Awards (FOYA) Submission Finalists . The following twelve projects met the rigorous qualifications and...